CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 180 filers reported holding CONMED CORP in Q2 2014. The put-call ratio across all filers is 3.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $446,000 | -64.3% | 3,407 | -77.4% | 0.00% | – |
| Q1 2019 | $1,251,000 | -78.3% | 15,048 | -83.3% | 0.00% | -100.0% |
| Q4 2018 | $5,771,000 | -42.4% | 89,900 | -57.2% | 0.00% | -66.7% |
| Q2 2016 | $10,016,000 | -13.1% | 209,838 | -23.6% | 0.00% | 0.0% |
| Q1 2016 | $11,522,000 | +46.9% | 274,726 | +67.2% | 0.00% | +50.0% |
| Q3 2015 | $7,845,000 | -28.5% | 164,320 | -12.7% | 0.00% | -33.3% |
| Q2 2015 | $10,966,000 | +22.2% | 188,196 | +5.9% | 0.00% | +50.0% |
| Q1 2015 | $8,975,000 | +25.9% | 177,766 | +12.1% | 0.00% | 0.0% |
| Q4 2014 | $7,127,000 | +23.3% | 158,526 | +1.0% | 0.00% | 0.0% |
| Q3 2014 | $5,781,000 | -15.2% | 156,891 | +1.7% | 0.00% | 0.0% |
| Q2 2014 | $6,814,000 | +4.6% | 154,341 | +2.9% | 0.00% | 0.0% |
| Q1 2014 | $6,515,000 | -8.8% | 149,951 | -10.8% | 0.00% | 0.0% |
| Q4 2013 | $7,142,000 | -54.7% | 168,048 | -63.7% | 0.00% | -60.0% |
| Q3 2013 | $15,752,000 | +188.6% | 463,456 | +165.2% | 0.01% | +150.0% |
| Q2 2013 | $5,459,000 | – | 174,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hood River Capital Management LLC | 448,126 | $38,346,000 | 1.80% |
| HealthCor Management, L.P. | 455,190 | $38,951,000 | 1.51% |
| Champlain Investment Partners, LLC | 1,452,360 | $124,278,000 | 1.04% |
| J. Goldman & Co LP | 162,771 | $13,928,000 | 0.96% |
| Granahan Investment Management | 189,925 | $16,252,000 | 0.80% |
| PURA VIDA INVESTMENTS, LLC | 50,000 | $4,279,000 | 0.65% |
| OAK RIDGE INVESTMENTS LLC | 102,797 | $8,797,000 | 0.61% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 78,722 | $6,736,000 | 0.54% |
| MOODY ALDRICH PARTNERS LLC | 23,834 | $2,039,000 | 0.52% |
| 361 CAPITAL LLC | 30,901 | $2,644,000 | 0.47% |